Moreover, A5-LNP-DOX treatment markedly suppressed tumor cell proliferation and angiogenesis, as indicated by a decrease in Ki67-positive cells and reduced CD31-labeled microvessel density (Fig. 6g, top and middle, respectively). The gene discussed is PECAM1; the disease is neoplasm.